Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M Shigeru.

Similar presentations


Presentation on theme: "Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M Shigeru."— Presentation transcript:

1 Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M Shigeru Kawabata, José R. Mercado-Matos, M. Christine Hollander, Danielle Donahue, Willie Wilson, Lucia Regales, Mohit Butaney, William Pao, Kwok-Kin Wong, Pasi A. Jänne, Phillip A. Dennis Cell Reports Volume 7, Issue 6, Pages 1824-1832 (June 2014) DOI: 10.1016/j.celrep.2014.05.039 Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

2 Figure 1 Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

3 Figure 2 Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

4 Figure 3 Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

5 Figure 4 Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

6 Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions


Download ppt "Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M Shigeru."

Similar presentations


Ads by Google